Literature DB >> 31308045

APE1 Upregulates MMP-14 via Redox-Sensitive ARF6-Mediated Recycling to Promote Cell Invasion of Esophageal Adenocarcinoma.

Heng Lu1, Ajaz A Bhat2, Dunfa Peng1, Zheng Chen1,3, Shoumin Zhu1, Jun Hong4, Selma Maacha2, Jin Yan5, David J Robbins1, M Kay Washington6, Abbes Belkhiri4, Wael El-Rifai7,3,8.   

Abstract

Esophageal adenocarcinoma (EAC) is an aggressive malignancy with poor clinical outcome. The incidence of EAC has been rising rapidly in the past three decades. Here, we showed that apurinic/apyrimidinic endonuclease (APE1) is overexpressed in EAC cell lines, and patients' samples of dysplasia and EAC. Downregulation of APE1 or inhibition of its redox function significantly repressed invasion. Overexpression of a redox-defective mutant, C65A, abrogated the proinvasive phenotype of APE1. APE1 regulated invasion via upregulation of matrix metalloproteinase 14 (MMP-14), which subsequently activated MMP-2, leading to degradation of the extracellular matrix in a redox-dependent manner. Downregulation of APE1 or inhibition of its redox function decreased the rate of endocytosis and recycling of MMP-14 protein. APE1 interacted with ARF6, a key regulator of MMP-14 recycling, which maintained ARF6 activity in an APE1-redox-dependent manner, promoting its ability to regulate MMP-14 recycling to the cell surface. In summary, these findings identify a novel redox-sensitive APE1-ARF6-MMP-14 signaling axis that mediates cellular invasion in esophageal carcinogenesis. SIGNIFICANCE: This study demonstrates the association between oxidative stress and the development and metastatic behavior of esophageal adenocarcinoma. ©2019 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31308045      PMCID: PMC6726537          DOI: 10.1158/0008-5472.CAN-19-0237

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  55 in total

Review 1.  Mechanisms of angiogenesis and arteriogenesis.

Authors:  P Carmeliet
Journal:  Nat Med       Date:  2000-04       Impact factor: 53.440

Review 2.  Adenocarcinoma of oesophagus: what exactly is the size of the problem and who is at risk?

Authors:  J Lagergren
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

Review 3.  Matrix metalloproteinases and angiogenesis.

Authors:  Joyce E Rundhaug
Journal:  J Cell Mol Med       Date:  2005 Apr-Jun       Impact factor: 5.310

4.  Toxic bile acids in gastro-oesophageal reflux disease: influence of gastric acidity.

Authors:  D Nehra; P Howell; C P Williams; J K Pye; J Beynon
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

Review 5.  Bile acids and Barrett's oesophagus: a sine qua non or coincidence?

Authors:  Rudy R Sital; Johannes G Kusters; Felix W M De Rooij; Ernst J Kuipers; Peter D Siersema
Journal:  Scand J Gastroenterol Suppl       Date:  2006

6.  FAK-mediated src phosphorylation of endophilin A2 inhibits endocytosis of MT1-MMP and promotes ECM degradation.

Authors:  Xiaoyang Wu; Boyi Gan; Youngdong Yoo; Jun-Lin Guan
Journal:  Dev Cell       Date:  2005-08       Impact factor: 12.270

7.  Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion.

Authors:  Y Itoh; A Takamura; N Ito; Y Maru; H Sato; N Suenaga; T Aoki; M Seiki
Journal:  EMBO J       Date:  2001-09-03       Impact factor: 11.598

8.  Activation of the promoters of genes associated with DNA damage, oxidative stress, ER stress and protein malfolding by the bile salt, deoxycholate.

Authors:  H Bernstein; C M Payne; C Bernstein; J Schneider; S E Beard; C L Crowley
Journal:  Toxicol Lett       Date:  1999-07-30       Impact factor: 4.372

Review 9.  MT1-MMP and MMP-7 in invasion and metastasis of human cancers.

Authors:  Takayuki Shiomi; Yasunori Okada
Journal:  Cancer Metastasis Rev       Date:  2003 Jun-Sep       Impact factor: 9.264

10.  Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors.

Authors:  Sunyoung Lee; Shahla M Jilani; Ganka V Nikolova; Darren Carpizo; M Luisa Iruela-Arispe
Journal:  J Cell Biol       Date:  2005-05-23       Impact factor: 10.539

View more
  7 in total

Review 1.  Esophageal Cancer Development: Crucial Clues Arising from the Extracellular Matrix.

Authors:  Antonio Palumbo; Nathalia Meireles Da Costa; Bruno Pontes; Felipe Leite de Oliveira; Matheus Lohan Codeço; Luis Felipe Ribeiro Pinto; Luiz Eurico Nasciutti
Journal:  Cells       Date:  2020-02-17       Impact factor: 6.600

Review 2.  Cytokine-chemokine network driven metastasis in esophageal cancer; promising avenue for targeted therapy.

Authors:  Ajaz A Bhat; Sabah Nisar; Selma Maacha; Tatiana Correa Carneiro-Lobo; Sabah Akhtar; Kodappully Sivaraman Siveen; Nissar A Wani; Arshi Rizwan; Puneet Bagga; Mayank Singh; Ravinder Reddy; Shahab Uddin; Jean-Charles Grivel; Gyan Chand; Michael P Frenneaux; Mushtaq A Siddiqi; Davide Bedognetti; Wael El-Rifai; Muzafar A Macha; Mohammad Haris
Journal:  Mol Cancer       Date:  2021-01-04       Impact factor: 27.401

Review 3.  Emerging technologies provide insights on cancer extracellular matrix biology and therapeutics.

Authors:  Ricardo Cruz-Acuña; Gordana Vunjak-Novakovic; Jason A Burdick; Anil K Rustgi
Journal:  iScience       Date:  2021-04-26

4.  Novel epigenetic network biomarkers for early detection of esophageal cancer.

Authors:  Alok K Maity; Timothy C Stone; Vanessa Ward; Amy P Webster; Zhen Yang; Aine Hogan; Hazel McBain; Margaraet Duku; Kai Man Alexander Ho; Paul Wolfson; David G Graham; Stephan Beck; Andrew E Teschendorff; Laurence B Lovat
Journal:  Clin Epigenetics       Date:  2022-02-14       Impact factor: 6.551

5.  ADP-ribosylation factor 6 expression increase in oesophageal adenocarcinoma suggests a potential biomarker role for it.

Authors:  Venkateswarlu Kanamarlapudi; Salman Tamaddon-Jahromi; Kate Murphy
Journal:  PLoS One       Date:  2022-02-10       Impact factor: 3.240

6.  APE1 redox function is required for activation of Yes-associated protein 1 under reflux conditions in Barrett's-associated esophageal adenocarcinomas.

Authors:  Farah Ballout; Heng Lu; Lei Chen; Kannappan Sriramajayam; Jianwen Que; Zhipeng Meng; Timothy C Wang; Silvia Giordano; Alexander Zaika; Oliver McDonald; Dunfa Peng; Wael El-Rifai
Journal:  J Exp Clin Cancer Res       Date:  2022-09-01

Review 7.  The multifunctional APE1 DNA repair-redox signaling protein as a drug target in human disease.

Authors:  Rachel A Caston; Silpa Gampala; Lee Armstrong; Richard A Messmann; Melissa L Fishel; Mark R Kelley
Journal:  Drug Discov Today       Date:  2020-10-24       Impact factor: 7.851

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.